DeepCyte Launches World's First Single-Cell Mechanistic Toxicity Atlas as Enterprise Pharma Pilots Advance

Contributed by: PR Newswire

Tags

DeepCyte-DeeToxAtlas

More Like This

DeepCyte Raises $1.5M to Bring Single-Cell AI Toxicology to Drug Development

ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones

PR Newswire associated0

ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.

PR Newswire associated0

Cellply launches its end-to-end single cell potency characterization platform VivaCyte

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies

Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery

PR Newswire associated0

Aignostics Launches AI-Powered Application for Tumor Microenvironment Profiling